Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | PRKCA | P17252 | 3/20 | 0.45 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.45 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.45 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.45 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.44 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.44 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.43 |
| ▸ | TLR2 | O60603 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26045881 | 0.87 | LPAR1 (0.59) | NAAAALDH1A1LMNAPRKCAPRKCE | |
| SCHEMBL11297774 | 0.87 | LPAR1 (0.46) | NAAAALDH1A1LMNALPAR1LPAR3 | |
| SCHEMBL2195313 | 0.85 | LPAR1 (0.56) | NAAAALDH1A1LMNAPRKCAPRKCE | |
| SCHEMBL11297776 | 0.85 | LPAR1 (0.45) | NAAAALDH1A1LMNALPAR1LPAR3 | |
| SCHEMBL18699114 | 0.84 | DNM1 (0.47) | NAAAALDH1A1LMNALPAR1LPAR3 | |
| SCHEMBL19227188 | 0.84 | DNM1 (0.47) | NAAAALDH1A1LMNALPAR1LPAR3 | |
| SCHEMBL18041137 | 0.83 | ALDH1A1 (0.60) | NAAAALDH1A1LMNAPRKCAPRKCE | |
| SCHEMBL27793214 | 0.83 | LMNA (0.64) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| Ammonia Solution, Strong SCHEMBL6303935 | 0.82 | NAAA (0.59) | NAAAALDH1A1LMNADNM1MAPT | |
| SCHEMBL446039 | 0.81 | NAAA (0.48) | NAAAALDH1A1LMNAPRKCAPRKCE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3202760-A1 | PEGYLATED LIPIDS AND THEIR USE FOR DRUG DELIVERY | Alnylam Pharmaceuticals, Inc. (US) | 2017-08-09 | — | — | EP | disclosed |